Jan Smeets

588 total citations
8 papers, 421 citations indexed

About

Jan Smeets is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Jan Smeets has authored 8 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Jan Smeets's work include Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (2 papers). Jan Smeets is often cited by papers focused on Estrogen and related hormone effects (6 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (2 papers). Jan Smeets collaborates with scholars based in Netherlands, United Kingdom and United States. Jan Smeets's co-authors include Christos Markopoulos, Robert Paridaens, Annette Hasenburg, Hein Putter, Yasuo Hozumi, E.T.M. Hille, Lina Asmar, Daniel Rea, Caroline Seynaeve and J.W.R. Nortier and has published in prestigious journals such as The Lancet, Cancer and Cancer Research.

In The Last Decade

Jan Smeets

8 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Smeets Netherlands 7 282 261 218 110 47 8 421
A. Fini Italy 6 450 1.6× 334 1.3× 352 1.6× 99 0.9× 49 1.0× 9 585
M. Rinaldini Italy 6 501 1.8× 406 1.6× 401 1.8× 130 1.2× 60 1.3× 9 664
Kate Whelan United States 5 188 0.7× 261 1.0× 246 1.1× 173 1.6× 35 0.7× 9 485
Juliette Murray United Kingdom 11 275 1.0× 312 1.2× 276 1.3× 90 0.8× 137 2.9× 27 532
G Gucciardo Italy 7 282 1.0× 248 1.0× 230 1.1× 48 0.4× 94 2.0× 12 550
Domen Ribnikar Canada 11 104 0.4× 291 1.1× 199 0.9× 151 1.4× 97 2.1× 31 470
Roberto Travaglini Italy 6 333 1.2× 245 0.9× 222 1.0× 47 0.4× 61 1.3× 8 509
T Palva Finland 8 277 1.0× 426 1.6× 179 0.8× 145 1.3× 61 1.3× 13 663
Jan Michel Switzerland 5 380 1.3× 330 1.3× 282 1.3× 242 2.2× 66 1.4× 6 650
Serafino Conforti Italy 7 194 0.7× 158 0.6× 111 0.5× 47 0.4× 98 2.1× 15 376

Countries citing papers authored by Jan Smeets

Since Specialization
Citations

This map shows the geographic impact of Jan Smeets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Smeets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Smeets more than expected).

Fields of papers citing papers by Jan Smeets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Smeets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Smeets. The network helps show where Jan Smeets may publish in the future.

Co-authorship network of co-authors of Jan Smeets

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Smeets. A scholar is included among the top collaborators of Jan Smeets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Smeets. Jan Smeets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Derks, Marloes G.M., Erik J. Blok, Caroline Seynaeve, et al.. (2017). Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 18(9). 1211–1220. 38 indexed citations
2.
Velde, Cornelis JH van de, Daniel Rea, Caroline Seynaeve, et al.. (2011). Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. The Lancet. 377(9762). 321–331. 264 indexed citations
3.
Seynaeve, Caroline, Annette Hasenburg, Daniel Rea, et al.. (2009). 2BA Results of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early breast cancer. European Journal of Cancer Supplements. 7(3). 1–1. 8 indexed citations
4.
5.
6.
Hupperets, P., Lex Volovics, Leo J. Schouten, et al.. (1993). Adjuvant chemohormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate for node-positive breast cancer patients. Annals of Oncology. 4(4). 295–301. 17 indexed citations
7.
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Fini Breakdown of academic impact, for papers by M. Rinaldini Breakdown of academic impact, for papers by Kate Whelan Breakdown of academic impact, for papers by Juliette Murray Breakdown of academic impact, for papers by G Gucciardo Breakdown of academic impact, for papers by Domen Ribnikar Breakdown of academic impact, for papers by Roberto Travaglini Breakdown of academic impact, for papers by T Palva Breakdown of academic impact, for papers by Jan Michel Breakdown of academic impact, for papers by Serafino Conforti
Rankless by CCL
2026